Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2572 (LINC02572) is a non-coding RNA locus producing long intergenic non-coding transcripts. LINC02572 is autonomously transcribed and does not encode a protein, nor does it overlap any annotated protein-coding gene. Members of the lincRNA family generally modulate gene expression at multiple levels, including chromatin configuration, RNA stability, and transcription regulation, and may possess enhancer-like functions. LINC02572 itself is one of many lincRNAs whose specific function remains to be elucidated, but lincRNAs as a class are increasingly recognized for their roles in fine-tuning cellular gene regulation, development, and disease, especially cancer. There is currently no evidence that LINC02572 is directly targeted by therapeutic drugs or used as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2572 (LINC02572).